[1]TetrahedronLetters,2014,vol.55,p.5186-5190
[1]CurrentPatentAssignee:KARUSTHERAPEUTICSLIMITED-WO2019/166824,2019,A1Locationinpatent:Page/Pagecolumn148;149
65456-22-6
756423-54-8
21443-15-2
898808-63-4
71676-01-2 | 4-AMino-N-[(1-ethyl-2-pyrrolidinyl)Methyl]-5-(ethylsulfonyl)- 2-MethoxybenzaMide N-Oxide | AA00FDC9 | MFCD24386580
72296-47-0 | ApovincaMinic Acid Hydrochloride Salt | AA00FDJS | MFCD28899172
73196-87-9 | 2',3',5'-TRI-O-ACETYL-2N,2N-DIMETHYL-GUANOSINE | AA00FDS4 | MFCD09841352
69392-64-9 | 4,5-Dichloro-2,3-dihydro-1h-inden-1-one | AA00FE0O | MFCD13190286
6641-32-3 | 4,5-Dichloropyridazine-3,6-diol | AA00FEET | MFCD00834958
684221-26-9 | 2-Cyclopentylethanamine HCl | AA00FF8W | MFCD09866300
669773-34-6 | 4,6-Dibromodibenzo[b,d]thiophene | AA00FFKJ | MFCD18451473
685107-91-9 | N'-Hydroxy-1-(thiazol-2-yl)-1H-pyrrole-2-carboximidamide | AA00FFWK | MFCD03617498
740841-15-0 | GSK-3 Inhibitor X | AA00FGBF | MFCD09037533
74733-29-2 | Methyl 2-fluoro-4-methylbenzoate | AA00FGNA | MFCD06204168